-

Bolivia Construction Industry Report 2023: Output Projected to Grow by 2.4% in Real Terms for 2023 Before Recording an AAGR of 4.1% for 2024-2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bolivia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Construction industry in Bolivia to expand by 2.4% in real terms in 2023, before recording average annual growth of 4.1% from 2024 to 2027.

The industry's output over the forecast period will be supported by investments in the transport, renewable energy, and residential sectors. In the General State Budget (PGE) for 2023, BOB27.6 billion ($4 billion) was allocated for public investment this year.

This includes an allocation of BOB11.7 billion ($1.7 billion) for the manufacturing sector, BOB6.9 billion ($1 billion) for the social sector, BOB6.6 billion ($955.1 million) for the infrastructure sector and BOB2.4 billion ($347.3 million) for multisectoral strategic projects.

The industry's growth over the forecast period will also be supported by investments in the mining sector. According to President Luis Arce, Bolivia has the world's largest reserve of lithium, totaling 23 million tons. In late July 2023, President Arce reported that construction will soon begin on a highway and high-voltage electric line to accommodate the Direct Lithium Extraction (DLE) plant that will be built by the Chinese consortium CBC in Coipasa.

Previously in January 2023, CBC announced that it will invest BOB9.7 billion ($1.4 billion) in DLE facilities in Coipasa and at the Uyuni salt flats, which accounts for a large share of Bolivia's lithium reserves.

Forecast-period growth in the Bolivian construction industry will also be supported by the Economic and Social Development Plan (PDES) 2021-2025, which includes an allocation of BOB229.4 billion ($33.2 billion) over the five-year period to develop the country's overall infrastructure.

Scope

  • Historical (2018-2022) and forecast (2023-2027) valuations of the construction industry in Bolivia, featuring details of key growth drivers.
  • Segmentation by sector (commercial, industrial, infrastructure, energy and utilities, institutional and residential) and by sub-sector
  • Analysis of the mega-project pipeline, including breakdowns by development stage across all sectors, and projected spending on projects in the existing pipeline.
  • Listings of major projects, in addition to details of leading contractors and consultants

Reasons to Buy

  • Identify and evaluate market opportunities using the publisher's standardized valuation and forecasting methodologies.
  • Assess market growth potential at a micro-level with over 600 time-series data forecasts.
  • Understand the latest industry and market trends.
  • Formulate and validate strategy using the publisher's critical and actionable insight.
  • Assess business risks, including cost, regulatory and competitive pressures.
  • Evaluate competitive risk and success factors.

Key Topics Covered:

1 Executive Summary

2 Construction Industry: At-a-Glance

3 Latest news and developments

4 Project analytics

5 Construction Market Data

6 Risk Profile

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/gpf6y6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom